When was NeuroLutions founded?

NeuroLutions was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Where is NeuroLutions located?

NeuroLutions is headquartered in St. Louis, United States. It is registered at Santa Cruz, California.

How many employees does NeuroLutions have?

As of Mar 31, 2026, the latest employee count at NeuroLutions is 92.

Is NeuroLutions a funded company?

NeuroLutions is a funded company, having raised a total of $28.3M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 2008.

When was the latest funding round of NeuroLutions?

NeuroLutions' latest funding was a $***** Series A round on Feb 14, 2025, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $5.85B in funding in 2026 to date.

Where does NeuroLutions rank among its competitors?

NeuroLutions ranks 10th amongst 112 active competitors, of which 35 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was MedRhythms, which secured $1M in Jul, 2026.

Who are the top competitors of NeuroLutions?

NeuroLutions' top competitors include MicroTransponder, Blackrock Neurotech and Perfuze. Among them, MedRhythms secured the most recent funding round in July, 2026.

NeuroLutions - 2026 Company Profile, Team, Funding & Competitors

NeuroLutions is a series A company based in St. Louis (United States), founded in 2007 by Daniel Moran. It operates as a Developer of robotic glove controlled by brain. NeuroLutions has raised $28.3M in funding from investors like Prolog Ventures, Ascension Ventures and BioGenerator. The company has 112 active competitors, including 35 funded and 6 that have exited. Its top competitors include companies like MicroTransponder, Blackrock Neurotech and Perfuze.

Company Details

NeuroLutions is developing devices based on brain-computer interface technology restoring functions in patients disabled due to neurological injury. It is developing a robotic glove that the user can wear it on their hand and a headset.

Website: www.neurolutions.com/
Social
Registered Address: Santa Cruz, California

Key Metrics

Founded Year

2007

Location

St. Louis, United States

Stage

Series A

Total Funding

$28.3M in 4 rounds

Latest Funding Round

Series A, Feb 14, 2025, $*****

Investors

Prolog Ventures & 7 more

Ranked

10^th among 112 active competitors

Employee Count

92 as on Mar 31, 2026

Similar Companies

MicroTransponder & 124 more

View NeuroLutions' full profile

NeuroLutions is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Neurolutions, Inc. CIN: 262913648 , United States, Active	Dec 26, 999	-	35 (As on Dec 31, 2024)	-

NeuroLutions has raised a total funding of $28.3M over 4 rounds. Its first funding round was on Nov 2008. NeuroLutions has 8 institutional investors.

Here is the list of recent funding rounds of NeuroLutions:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 14, 2025	1427429	Series A	1532578	7332700	8431217	8873219
Sep 01, 2022	1628534	Grant (prize money)	8522029	3573559	1551936	HHS
Jun 10, 2015	6390235	Seed	2367805	6375762	Prolog Ventures & 2 more	6023695

Access funding benchmarks and valuations. Sign up today!

View details of NeuroLutions's funding rounds and investors

The founders of NeuroLutions is Daniel Moran.

Here are the details of NeuroLutions' key team members:

Daniel Moran: Co-Founder of NeuroLutions and founder of 1 other company.

NeuroLutions' Board of Directors

NeuroLutions's board has 7 active members. Stavros Vizirgianakis, Fred Khosravi, Leo Petrossian, Kevin Reilly, Amarpreet Sawhney, Yuanwei Tai and Eric Leuthardt are independent board members.

Here is the list of NeuroLutions' board of directors:

Name	Type	Representing	Status	Duration
Stavros Vizirgianakis	Independent board member	-	Current	1y 5m
knklxsz	Independent board member	-	Current	7y 8m
tshkhpy	Independent board member	-	Current	4y 9m
jftdtmv	Independent board member	-	Current	3y 2m
q{k{bzu	Independent board member	-	Current	1y 1m
irsucar	Independent board member	-	Current	9y 1m
jgkxtey	Independent board member	-	Current	9y 3m

View details of NeuroLutions's Founder profiles and Board Members

NeuroLutions' employee count trend

NeuroLutions has 92 employees as of Mar 26. Here is NeuroLutions's employee count trend over the years:

Uncover NeuroLutions' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroLutions include MicroTransponder, Blackrock Neurotech and Perfuze. Here is the list of Top 10 competitors of NeuroLutions, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MicroTransponder 2007, Dallas (United States), Series F	Developer of neuromodulation therapy for neurological conditions	$180M	USVP, Green Park & Golf Ventures & 11 others	63/100
2nd	Blackrock Neurotech 2008, Salt Lake City (United States), Acquired	Developer of medical devices for neurological therapies	$22.4M	re.Mind Capital, Cavendish Privateers & 12 others	62/100
3rd	Perfuze 2018, Galway (Ireland), Series A	Developer of a medical device for the treatment of acute ischemic stroke	$53.2M	Earlybird, Seroba Lifesciences & 7 others	61/100
4th	Mainstay Medical 2008, Dublin (Ireland), Public	Provider of rehabilitation solutions for patients and doctors	$27.2M	Fountain Healthcare Partners, Sofinnova Partners ... & 11 others	60/100
5th	Conformal Medical 2016, Nashua (United States), Series D	Innovating stroke prevention with minimally invasive Left Atrial Appendage Occlusion	$161M	CHV, Sprig Equity & 4 others	57/100
6th	CorTec 2010, Freiburg im Breisgau (Germany), Series C	Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies	$21.6M	Santo Venture Capital, K & SW Consult & 7 others	57/100
7th	Enspire DBS Therapy 2010, Chagrin Falls (United States), Series B	Developer of stroke recovery therapy	$27.9M	Cleveland Clinic, Genesys Capital & 3 others	52/100
8th	Flint Rehab 2011, Irvine (United States), Early Stage	Developer of stroke rehabilitation systems	$8M	NICHD, HHS & 1 others	51/100
9th	MedRhythms 2013, Boston (United States), Series B	Provider of wearable devices to combat neurological injuries and recover walking functions	$64.2M	Morningside, Advantage Capital & 10 others	51/100
10th	NeuroLutions 2007, St. Louis (United States), Series A	Developer of robotic glove controlled by brain	$28.3M	Techlink Ventures, Ascension Ventures & 6 others	48/100